+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Genitourinary Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 144 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5901533
Description Jump to:
The global genitourinary drugs market size reached US$ 32.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 37.0 Billion by 2028, exhibiting a growth rate (CAGR) of 2.2% during 2022-2028.

The genitourinary system includes kidneys, ureters, bladder, urethra, and genital organs, which play a vital role in reproduction and getting rid of waste products from the body. Its functioning can be hampered on account of congenital abnormalities, iatrogenic injuries, cancer, trauma, infections, hydronephrosis, and inflammation. Due to the rising number of individuals suffering from these diseases, there is a rise in the demand for genitourinary drugs across the globe. Genitourinary drugs help treat the reproductive organs, excretory system, and urinary tract conditions. They are also used in the treatment of bladder spasms and erectile dysfunction and suppressing uterine contractions to prevent preterm labor.

Genitourinary Drugs Market Trends:

The increasing risk of genitourinary organ damage represents one of the major factors influencing the growth of the market. Moreover, as genitourinary drugs are effective in treating the pediatric population with chronic kidney failure and urinary tract infections, their sales are increasing around the world. Apart from this, the leading market players are focusing on advancing formulation techniques to introduce drugs that help treat chronic prostate cancer patients who have developed resistance to conventional chemotherapeutic and hormone therapy agents. Furthermore, several multinational companies (MNCs) are collaborating with biopharmaceutical leaders to launch next-generation therapeutics and strengthen their position in the market. This, in confluence with a considerable rise in the number of pipeline drugs in late-stage clinical trials, is contributing to the market growth. Besides this, the increasing funding for research and development (R&D) projects, along with improvements in the healthcare infrastructure sponsored by governing and non-governing agencies of numerous countries, is anticipated to drive the demand for genitourinary drugs in the coming years.

Key Market Segmentation:

The publisher provides an analysis of the key trends in each sub-segment of the global genitourinary drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on indication and product.

Breakup by Indication:

  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Renal Cancer
  • Erectile Dysfunction
  • Urinary Tract Infections
  • Urinary Incontinence and Overactive Bladder
  • Sexually Transmitted Diseases
  • Interstitial Cystitis
  • Hematuria
  • Benign Prostatic Hyperplasia

Breakup by Product:

  • Urological
  • Hormonal Therapy
  • Gynecological
  • Anti-infectives
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allergan plc (AbbVie Inc.), Antares Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Genentech Inc. (Roche Holding AG), GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Key Questions Answered in This Report

1. How big is the global genitourinary drugs market?
2. What is the expected growth rate of the global genitourinary drugs market during 2023-2028?
3. What are the key factors driving the global genitourinary drugs market?
4. What has been the impact of COVID-19 on the global genitourinary drugs market?
5. What is the breakup of the global genitourinary drugs market based on the indication?
6. What is the breakup of the global genitourinary drugs market based on the product?
7. What are the key regions in the global genitourinary drugs market?
8. Who are the key players/companies in the global genitourinary drugs market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genitourinary Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Prostate Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovarian Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Bladder Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cervical Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Renal Cancer
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Erectile Dysfunction
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Urinary Tract Infections
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Urinary Incontinence and Overactive Bladder
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Sexually Transmitted Diseases
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Interstitial Cystitis
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Hematuria
6.11.1 Market Trends
6.11.2 Market Forecast
6.12 Benign Prostatic Hyperplasia
6.12.1 Market Trends
6.12.2 Market Forecast
7 Market Breakup by Product
7.1 Urological
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hormonal Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Gynecological
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-infectives
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Allergan plc (AbbVie Inc.)
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 SWOT Analysis
13.3.2 Antares Pharma Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.3 AstraZeneca plc
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.4 Bayer AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Bristol-Myers Squibb Company
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Genentech Inc. (Roche Holding AG)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 SWOT Analysis
13.3.7 GlaxoSmithKline plc
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Merck & Co. Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Teva Pharmaceutical Industries Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
List of Figures
Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2022
Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2022
Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2022
Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2022
Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Genitourinary Drugs Market: Competitive Structure
Table 6: Global: Genitourinary Drugs Market: Key Players

Companies Mentioned

  • Allergan plc (AbbVie Inc.)
  • Antares Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Genentech Inc. (Roche Holding AG)
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc. and Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages144
PublishedNovember 2023
Forecast Period2022 - 2028
Estimated Market Value ( USD ) in 2022 $ 32.4 Billion
Forecasted Market Value ( USD ) by 2028 $ 37 Billion
Compound Annual Growth Rate2.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Genitourinary Drugs Market by Product (Anti-infectives, Gynecological, Hormonal Therapy), Indication (Benign Prostatic Hyperplasia, Bladder Cancer, Cervical Cancer), Drug Type - Forecast 2024-2030 - Product Image

Global Genitourinary Drugs Market by Product (Anti-infectives, Gynecological, Hormonal Therapy), Indication (Benign Prostatic Hyperplasia, Bladder Cancer, Cervical Cancer), Drug Type - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Genitourinary Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, and Product Type - Product Image

Genitourinary Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, and Product Type

  • Report
  • 105 Pages
  • Global
From
Genitourinary Drugs: Global Strategic Business Report - Product Image

Genitourinary Drugs: Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Genitourinary Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Genitourinary Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 181 Pages
  • Global
From
Global Genitourinary Drugs Market Report and Forecast 2023-2031 - Product Image

Global Genitourinary Drugs Market Report and Forecast 2023-2031

  • Report
  • 147 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.